Few children affected by monkeypox so far – But risks are higher in children 8 or younger

Children aged 8 years or younger should be considered a group at high risk for more severe monkeypox disease, reports The Pediatric Infectious Disease Journal, the official journal of The European Society for Pediatric Infectious Diseases. The journal is published in the Lippincott portfolio by Wolters Kluwer.

Cancer Patients Treated with Immunotherapy Can Safely Receive mRNA COVID-19 Vaccines, According to JNCCN Study

New research published in the October 2022 issue of JNCCN—Journal of the National Comprehensive Cancer Network confirms the safety of mRNA vaccines in people with cancer undergoing immunotherapy treatment.

UCLA Fielding School of Public Health-led research demonstrates the importance of influenza vaccination globally

An international team of researchers has demonstrated that among patients hospitalized for influenza, those who were vaccinated had less severe infections, including reducing the odds for children requiring admittance to an intensive care unit by almost half.

Houston Methodist seeing December flu season peak numbers now

Texas already has a moderately high rate of flu cases in September. This doesn’t look good for flu season, which was uncharacteristically low last year because of masks and people isolating. Houston Methodist experts are encouraging the community to get the flu shot early. Experts say cases aren’t usually seen this high until December, which is when the season usually peaks.

Current vaccine approach not enough to eradicate measles

Current vaccination strategies are unlikely to eliminate measles, according to a new study led by faculty at the University of Georgia. The paper, which published today in The Lancet Global Health, explores the feasibility of eliminating measles and rubella using predominant vaccination strategies in 93 countries with the highest disease burden.

New study finds COVID-19 booster increases antibodies by more than 85% in nursing home residents and their caregivers

The study found that Omicron-specific antibodies reached detectable levels in 86% of nursing home residents and 93% of healthcare workers after receiving the booster shot, compared to just 28% of nursing home residents and healthcare workers after the initial two-dose COVID-19 vaccine series.

COVID-19 vaccine incentives get mixed reception from young people

Offering teens and young adults a chance at a college scholarship, cash, discounts or just some free food might help move the needle on COVID-19 vaccination rates, a new study suggests. In all, 82% of people between the ages of 14 and 24 have a positive attitude toward prizes, raffles, giveaways, and other incentives designed to increase vaccination. But a sizable minority of young people have their doubts about whether such vaccine incentives will work or are ethical.

Comparing SARS-CoV-2 antibody response after Moderna, Pfizer-BioNTech vaccines in immunosuppressed patients

About The Study: Researchers compared antispike antibody titers after the 2-dose Pfizer-BioNTech and Moderna COVID-19 vaccines in incrementally immunosuppressed patients. These individuals, such as people with rheumatic and musculoskeletal diseases and solid organ transplant recipients, have decreased immune responses to these…

Rutgers Expert Available to Discuss Mixing and Matching of COVID-19 Vaccines, Booster Shots

Rutgers infectious disease expert Shobha Swaminathan is available to discuss the mixing and matching of COVID-19 vaccines and boosters as the Food and Drugs Administration authorized booster shots for both the Johnson & Johnson and Moderna vaccines. “There is mounting…

In pregnant women with COVID-19, sex of fetus may influence maternal and placental immune response and neonatal immune protection

In pregnant women who tested positive for SARS-CoV-2, the virus that causes COVID-19, male placentas demonstrated significantly higher levels of certain genes and proteins associated with increased immune activation compared with female placentas, according to a new study published in Science Translational Medicine.

Rutgers Chancellor Available to Discuss COVID-19 Booster Shots, Why Frontline Workers Need Them

Brian L. Strom, chancellor at the Rutgers Biomedical and Health Sciences and executive vice president for Rutgers Health Affairs, is available to discuss the COVID-19 booster shot and why frontline workers need to get them. Strom agrees with the Centers…

Rutgers Global Health Expert Available to Discuss the Global Need for More COVID-19 Vaccines

Rutgers global health expert Richard Marlink, M.D., is available to discuss the importance of prioritizing vaccinations in low- to middle-income countries that need it the most, following President Biden’s pledge to donate an additional 500 million doses of the Pfizer-BioNTech COVID-19…

10 questions you want answered on COVID-19

Should children under the age of 12 be vaccinated against COVID-19? Is it possible to achieve herd immunity? Will an 80 per cent vaccination rate keep us safe? In this video, UniSA epidemiologist Professor Adrian Esterman answers these questions and a lot more. The former World Health Organization consultant shares his expertise – 50 years’ worth – and argues for a different approach to tackling COVID-19.
https://www.youtube.com/watch?v=MLKC9q9yEto